Brain, Cranial & Nerve
Awake Craniotomy for Brain Tumor
Tumor removal with the patient comfortably awake for part of the operation — because function we can test in real time is function we can protect.
What it is
An awake craniotomy is a brain tumor operation in which you are comfortably awake for the critical portion — talking, naming pictures, moving your hand — while we map the surface and pathways of the brain around the tumor with a small electrical probe. The brain itself feels no pain; the scalp is thoroughly numbed, and you are asleep for the opening and closing.
The mapping tells us, in real time, exactly where speech, language, and movement live in your brain — which imaging alone cannot fully show, because these functions shift and vary from person to person, and tumors distort the usual anatomy. The boundary of the resection is drawn by your own function, tested continuously as we work.
Why this procedure when surgery is needed
For tumors in or near eloquent cortex — the regions controlling speech, language, and movement — the central question is not just how much tumor can come out, but how much can come out safely. Awake mapping answers that question directly rather than by inference: if a spot matters, testing shows it immediately, and we do not cross it.
The result, consistently, is the best available combination of maximal resection and preserved function. For many patients the deciding fact is simple: the alternative to being awake for an hour of testing is accepting either a smaller resection or a higher risk to the abilities that matter most.
What to expect
Before surgery, we rehearse the tasks you'll perform — naming, counting, moving — so nothing during the operation is unfamiliar.
You are asleep for the opening, gently awakened for the mapping and tumor removal, and asleep again for the closing. Most patients describe the awake portion as strange but not painful.
A dedicated team member talks with you and runs the testing the entire time you are awake.
Hospital stay of 2–4 nights for most patients.
Temporary worsening of speech or strength in the first days is common when operating near these areas and usually improves over days to weeks.
Pathology results typically take 5–10 days; we meet to review them and plan next steps together.
Risks and how we reduce them
Awake mapping exists to reduce the most feared risk of tumor surgery — losing speech or movement — but it does not eliminate it, and the operation carries the standard risks of a craniotomy as well.
Expected, temporary effects
Temporary speech or motor worsening. Swelling around a freshly operated functional area commonly causes temporary word-finding trouble or weakness in the first days, which usually improves over days to weeks.
Fatigue, headaches, and incisional soreness. Short-term fatigue, headaches, and soreness along the incision are expected early and improve over weeks.
Serious risks
Seizure during mapping. Electrical stimulation of the brain can trigger a seizure during the operation; the team is prepared for this, treats it immediately with cold irrigation and medication, and it rarely changes the plan.
Permanent neurologic deficit. Despite mapping, lasting changes in speech, language, or strength can still occur — the mapping makes this uncommon, not impossible.
Conversion to asleep surgery. If testing cannot continue safely — from a seizure, airway concern, or discomfort — the operation is completed asleep, with a more conservative resection near untested areas.
Bleeding at the surgical site. Bleeding into the tumor bed after surgery is uncommon but can require a return to the operating room.
Stroke. Injury to a blood vessel during surgery can cause a stroke, with effects that depend on the area involved.
Infection. Wound infection or, rarely, meningitis can occur and is minimized with sterile technique and antibiotics.
CSF leak. Leakage of spinal fluid through the incision can occur and sometimes needs additional treatment.
Approach
- Functional MRI and detailed anatomic imaging for planning before surgery
- Image-guided navigation throughout the operation
- Scalp blocks and precisely titrated anesthesia — asleep, awake, asleep
- Direct cortical and subcortical stimulation mapping of speech, language, and motor pathways
- 5-ALA fluorescence guidance when a high-grade glioma is suspected
- Operating microscope for tumor removal up to the functional boundary
- Continuous task testing during resection near critical areas
Typical indications
- Tumor in or adjacent to speech, language, or motor cortex
- Tumor involving the subcortical pathways serving those functions
- Tumor types where extent of resection correlates with outcomes
- Patients able to participate in testing — rehearsed and prepared beforehand
- Re-operation where prior surgery or tumor has distorted functional anatomy
Alternatives we considered
- Standard asleep craniotomy with neuromonitoring for tumors clear of eloquent cortex
- Stereotactic biopsy alone for diagnosis when resection is not the right first step
- Stereotactic radiosurgery for small, well-defined lesions
- Observation with serial imaging for stable, asymptomatic tumors
Related conditions
This procedure is most often performed for:
Medical review in progress. Author: practice editorial team.
The information on this page is general patient education and is not a substitute for individualized medical advice. For urgent symptoms, call 911 or go to the nearest emergency department. For non-urgent questions, call (785) 368-0767 during clinic hours.
Not sure whether a symptom needs a call? When to call after surgery